Clinical Imaging
Volume 35, Issue 3 , Pages 165-173 , May 2011

The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma

  • Yinian Zhang

      Affiliations

    • Center for Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China
    • Department of Radiology, No. 2 Hospital of Lanzhou University, 80 Cuiying Men Road, Lanzhou 730030, China
    • ,
  • Ning He

      Affiliations

    • Department of Radiology, No. 2 Hospital of Lanzhou University, 80 Cuiying Men Road, Lanzhou 730030, China
    • ,
  • Junlin Zhou

      Affiliations

    • Department of Radiology, No. 2 Hospital of Lanzhou University, 80 Cuiying Men Road, Lanzhou 730030, China
    • ,
  • Yaqing Chen

      Affiliations

    • Center for Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China
    • Corresponding Author InformationCorresponding author. XinHua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China.

Received 25 March 2010 ,Accepted 15 April 2010.

References 

  1. Pan LX, Chen ZP, Liu YS, Zhao JH. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space. J Neurooncol. 2005;74:71–76
  2. Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33:610–617
  3. Cottier JP, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology. 2000;215:463–469
  4. Sarlis NJ, Gourgiotis L, Koch CA, Skarulis MC, Brucker-Davis F, Doppman JL, et al. MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation. AJR Am J Roentgenol. 2003;181:577–582
  5. Iuchi T, Saeki N, Osato K, Yamaura A. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas. Acta Neurochir (Wien). 2000;142:1345–1351
  6. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401–409
  7. Wolfsberger S, Ba-Ssalamah A, Pinker K, Mlynárik V, Czech T, Knosp E, et al. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions. J Neurosurg. 2004;100:278–286
  8. Zhou S, Liu C, Wu SM, Wu RL. Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis. Ai Zheng. 2005;24:874–879
  9. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem. 1997;272:24–27
  10. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int. 2006;56:359–367
  11. Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett. 2000;157:177–184
  12. Renno T, Wilson A, Dunkel C, Coste I, Maisnier-Patin K, Benoit de Coignac A, et al. A role for CD147 in thymic development. J Immunol. 2002;168:4946–4950
  13. Huo G, Tian JK, Tang WY, Zhen LP, Yi Y. The study on expression and relationship between matrix metalloproteinase-2 and CD147 in invasive pituitary adenomas. J Nerv Ment Dis. 2005;31:168–171
  14. Jin L, Riss D, Ruebel K, Kajita S, Scheithauer BW, Horvath E, et al. Galectin-3 expression in functioning and silent ACTH-producing adenomas. Endocr Pathol. 2005;16:107–114
  15. Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res. 2003;63:2251–2255
  16. Cerman J, Cap J, Marekova M, Nemecek S, Marek J, Rudolf E, et al. The role of apoptosis in pituitary adenomas in the field of conventionally used therapeutic approaches. Ann N Y Acad Sci. 2003;1010:520–524
  17. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab. 2000;85:1159–1162
  18. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch. 2001;438:596–602
  19. Itoh J, Serizawa A, Kawai K, Ishii Y, Teramoto A, Osamura RY. Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas. Microsc Res Tech. 2003;60:231–235
  20. Vieira JO, Cukiert A, Liberman B. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings. Surg Neurol. 2006;65:130–135
  21. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002;94:1854–1856

PII: S0899-7071(10)00108-7

doi: 10.1016/j.clinimag.2010.06.002

Clinical Imaging
Volume 35, Issue 3 , Pages 165-173 , May 2011

Article Tools

* Image Usage & Resolution